Nau C, Vogel W, Hempelmann G, Bräu M E
Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen, Germany.
Anesthesiology. 1999 Sep;91(3):786-95. doi: 10.1097/00000542-199909000-00031.
The local anesthetic bupivacaine exists in two stereoisomeric forms, R(+)- and S(-)-bupivacaine. Because of its lower cardiac and central nervous system toxicity, attempts were made recently to introduce S(-)-bupivacaine into clinical anesthesia. We investigated stereoselective actions of R(+)-and S(-)-bupivacaine toward two local anesthetic-sensitive ion channels in peripheral nerve, the Na+ and the flicker K+ channel.
In patch-clamp experiments on enzymatically demyelinated peripheral amphibian nerve fibers, Na+ and flicker K+ channels were investigated in outside-out patches. Half-maximum inhibiting concentrations (IC50) were determined. For the flicker K+ channel, simultaneous block by R(+)-bupivacaine and S(-)-bupivacaine was analyzed for competition and association (k1) and dissociation rate constants (k(-1)) were determined.
Both channels were reversibly blocked by R(+)- and S(-)-bupivacaine. The IC50 values (+/- SEM) for tonic Na+ channel block were 29+/-3 microM and 44+/-3 microM, respectively. IC50 values for flicker K+ channel block were 0.15+/-0.02 microM and 11+/-1 microM, respectively, resulting in a high stereopotency ratio (+/-) of 73. Simultaneously applied enantiomers competed for a single binding site. Rate constants k1 and k(-1) were 0.83+/-0.13x10(6) M(-1) x S(-1) and 0.13+/-0.03 s(-1), respectively, for R(+)-bupivacaine and 1.90+/-0.20x10(6) M(-1) x s(-1) and 8.3+/-1.0 s(-1), respectively, for S(-)-bupivacaine.
Bupivacaine block of Na+ channels shows no salient stereoselectivity. Block of flicker K+ channels has the highest stereoselectivity ratio of bupivacaine action known so far. This stereoselectivity derives predominantly from a difference in k(-1), suggesting a tight fit between R(+)-bupivacaine and the binding site. The flicker K+ channel may play an important role in yet unknown toxic mechanisms of R(+)-bupivacaine.
局部麻醉药布比卡因存在两种立体异构形式,即R(+)-布比卡因和S(-)-布比卡因。由于其较低的心脏和中枢神经系统毒性,最近有人试图将S(-)-布比卡因引入临床麻醉。我们研究了R(+)-和S(-)-布比卡因对周围神经中两种局部麻醉药敏感离子通道,即Na+通道和闪烁K+通道的立体选择性作用。
在对酶解脱髓鞘的周围两栖类神经纤维进行的膜片钳实验中,在外侧向外膜片中研究了Na+通道和闪烁K+通道。测定半数最大抑制浓度(IC50)。对于闪烁K+通道,分析了R(+)-布比卡因和S(-)-布比卡因的同时阻断作用,以确定竞争、结合(k1)和解离速率常数(k(-1))。
两种通道均被R(+)-和S(-)-布比卡因可逆性阻断。持续性Na+通道阻断的IC50值(±SEM)分别为29±3 μM和44±3 μM。闪烁K+通道阻断的IC50值分别为0.15±0.02 μM和11±1 μM,导致高立体效价比(±)为73。同时应用的对映体竞争单个结合位点。R(+)-布比卡因的速率常数k1和k(-1)分别为0.83±0.13×10(6) M(-1)×s(-1)和0.13±0.03 s(-1),S(-)-布比卡因的分别为1.90±0.20×10(6) M(-1)×s(-1)和8.3±1.0 s(-1)。
布比卡因对Na+通道的阻断无明显立体选择性。闪烁K+通道的阻断具有布比卡因作用迄今已知的最高立体选择性比。这种立体选择性主要源于k(-1)的差异,提示R(+)-布比卡因与结合位点紧密契合。闪烁K+通道可能在R(+)-布比卡因未知的毒性机制中起重要作用。